Skip to main content
. Author manuscript; available in PMC: 2018 Jun 4.
Published in final edited form as: Theriogenology. 2014 May 21;82(3):481–489. doi: 10.1016/j.theriogenology.2014.05.011

Table 1.

Effect of treatment on number of follicles and CL, percentage of superovulated heifers, and ovulation rate for Holstein heifers induced to superovulate using a long-acting recombinant bovine FSH preparation (LArbFSH) or a pituitary-derived FSH preparation (Folltropin).

Item Folltropin A50-LArbFSH A100-LArbFSH B50-LArbFSH P value
n 14 14 14 14
Follicle numbera (min-max) 25.7 ± 3.2a (7-51) 5.9 ± 0.9c (0-11) 16.6 ± 3.1b (2-39) 18.9 ± 3.2ab (4-37) <0.01
CL numberb (min-max) 19.1 ± 2.4a (7-32) 2.6 ± 0.9b (0-11) 15.9 ± 2.9a (2-42) 16.1 ± 3.0a (2-39) <0.01
% Superovulatedc (n) 100 ± 0.0a (14) 28.6 ± 12.5b (4) 85.7 ± 9.7a (12) 92.9 ± 7.1a (13) <0.01
Ovulation rated 76.0 ± 4.8a 38.7 ± 10.6b 88.0 ± 4.2a 80.8 ± 4.9a <0.01

Within a row, means with different superscripts (a, b) differ (P < 0.05).

Heifers treated with Folltropin received 300 mg of FSH (Folltropin) in eight decreasing doses administered im at 12-hour intervals over a 4-day period, heifers treated with A50-LArbFSH received 50 μg of LArbFSH (type A) in a single im injection, heifers treated with A100-LArbFSH received 100 μg of LArbFSH (type A) in a single im injection, and heifers treated with B50-LArbFSH received 50 μg of LArbFSH (type B) in a single im injection.

a

Measured immediately before hCG treatment.

b

Measured immediately before embryo collection.

c

Heifers with three or more CL at the time of embryo collection.

d

Measured immediately before embryo collection, one heifer treated with A50-LArbFSH was excluded because no follicles greater than 9 mm or CL were detected.